<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=TOP1</id>
	<title>TOP1 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=TOP1"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=TOP1&amp;action=history"/>
	<updated>2026-04-11T13:00:25Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=TOP1&amp;diff=4320&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)  ==Publications==  {{medline-entry |title=UCHL3 Regulates Topoisomerase-Induced Chromosomal Break Repai...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=TOP1&amp;diff=4320&amp;oldid=prev"/>
		<updated>2021-04-29T19:11:55Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)  ==Publications==  {{medline-entry |title=&lt;a href=&quot;/index.php?title=UCHL3&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;UCHL3 (страница не существует)&quot;&gt;UCHL3&lt;/a&gt; Regulates Topoisomerase-Induced Chromosomal Break Repai...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;DNA topoisomerase 1 (EC 5.6.2.1) (DNA topoisomerase I)&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=[[UCHL3]] Regulates Topoisomerase-Induced Chromosomal Break Repair by Controlling [[TDP1]] Proteostasis.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/29898404&lt;br /&gt;
|abstract=Genomic damage can feature DNA-protein crosslinks whereby their acute accumulation is utilized to treat cancer and progressive accumulation causes neurodegeneration. This is typified by tyrosyl DNA phosphodiesterase 1 ([[TDP1]]), which repairs topoisomerase-mediated chromosomal breaks. Although [[TDP1]] levels vary in multiple clinical settings, the mechanism underpinning this variation is unknown. We reveal that [[TDP1]] is controlled by ubiquitylation and identify [[UCHL3]] as the deubiquitylase that controls [[TDP1]] proteostasis. Depletion of [[UCHL3]] increases [[TDP1]] ubiquitylation and turnover rate and sensitizes cells to [[TOP1]] poisons. Overexpression of [[UCHL3]], but not a catalytically inactive mutant, suppresses [[TDP1]] ubiquitylation and turnover rate. [[TDP1]] overexpression in the topoisomerase therapy-resistant rhabdomyosarcoma is driven by [[UCHL3]] overexpression. In contrast, [[UCHL3]] is downregulated in spinocerebellar ataxia with axonal neuropathy (SCAN1), causing elevated levels of [[TDP1]] ubiquitylation and faster turnover rate. These data establish [[UCHL3]] as a regulator of [[TDP1]] proteostasis and, consequently, a fine-tuner of protein-linked DNA break repair.&lt;br /&gt;
|mesh-terms=* Cell Line, Tumor&lt;br /&gt;
* Chromosome Breakage&lt;br /&gt;
* Cysteine Endopeptidases&lt;br /&gt;
* DNA Repair&lt;br /&gt;
* DNA Topoisomerases, Type I&lt;br /&gt;
* Down-Regulation&lt;br /&gt;
* HEK293 Cells&lt;br /&gt;
* Humans&lt;br /&gt;
* Nucleotidases&lt;br /&gt;
* Phosphoric Diester Hydrolases&lt;br /&gt;
* Proteostasis&lt;br /&gt;
* RNA Interference&lt;br /&gt;
* RNA, Small Interfering&lt;br /&gt;
* Ubiquitin&lt;br /&gt;
* Ubiquitin Thiolesterase&lt;br /&gt;
* Ubiquitination&lt;br /&gt;
* Up-Regulation&lt;br /&gt;
|keywords=* SCAN1&lt;br /&gt;
* TDP&lt;br /&gt;
* UCHL3&lt;br /&gt;
* aging&lt;br /&gt;
* cancer&lt;br /&gt;
* heart failure&lt;br /&gt;
* myocardial infarction&lt;br /&gt;
* neurodegeneration&lt;br /&gt;
* rhabdosarcoma&lt;br /&gt;
* topoisomerase&lt;br /&gt;
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019701&lt;br /&gt;
}}&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=mir-24 activity propagates stress-induced senescence by down regulating DNA topoisomerase 1.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26748253&lt;br /&gt;
|abstract=MicroRNAs (miRNAs) are a group of small non-coding executor RNAs. Their function as key modulators of cellular senescence has been widely recognized recently. By cross-comparing several human aging models we previously identified dozens of miRNAs being differentially regulated during aging. Here the functions of two miRNAs, mir-24 and mir-424, were investigated in an oxidative stress-induced fibroblast premature senescence model. Using pre-miRNA precursors, miRNAs were overexpressed in cells undergoing premature senescence induced by oxidative stress. More senescent cells were observed in mir-24 transfected cells. p53 was upregulated in mir-24 overexpressing cells, but downregulated in mir-424 overexpressing cells. DNA topoisomerase I ([[TOP1]]), an enzyme controlling DNA topology, was identified as a target of mir-24, whose expression was induced by oxidative stress. Knocking down [[TOP1]] induced cellular senescence. These results suggest that mir-24 activity propagates stress-induced senescence by down regulating [[TOP1]]. &lt;br /&gt;
|mesh-terms=* Cells, Cultured&lt;br /&gt;
* Cellular Senescence&lt;br /&gt;
* DNA Topoisomerases, Type I&lt;br /&gt;
* Down-Regulation&lt;br /&gt;
* Fibroblasts&lt;br /&gt;
* Gene Expression Regulation&lt;br /&gt;
* Humans&lt;br /&gt;
* MicroRNAs&lt;br /&gt;
* Oxidative Stress&lt;br /&gt;
* Transfection&lt;br /&gt;
|keywords=* Cellular senescence&lt;br /&gt;
* Oxidative stress&lt;br /&gt;
* TOP1&lt;br /&gt;
* miRNA&lt;br /&gt;
* mir-24&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1016/j.exger.2015.12.012&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>